Funding to ensure correct supplement labelling

- Last updated on GMT

Related tags: United states senate, Food and drug administration, Nutrition

As part of a new bill that passed on October 26 in the US, $1
million (1.15 million euros) was appropriated to ensure that proper
labelling and substantiated claims appear on dietary supplements.

As part of a new bill that passed on October 26 in the US, $1 million (1.15 million euros) was appropriated to ensure that proper labelling and substantiated claims appear on dietary supplements. The amendment introduced to the Senate Agriculture Appropriations Bill directs $1 million(1.15 million) euros to the Center for Food Services and Applied Nutrition (CFSAN) at the Food and Drug Administration (FDA) to "enhance enforcement"​ of the Dietary Supplement Health and Education Act (DSHEA). The funding would be spent on supporting accurate product labelling and truthful, substantiated claims. Senator Harkin, who introduced the bill, said, "This is an area of extreme importance to American consumers, literally millions of whom regularly take dietary supplements to maintain their health."​ He also cited studies and statistics that supported the reasoning behind giving money to DSHEA, as well as reporting on recent events that would have benefited from better labelling and substantiated claims on dietary supplements.

Related topics: Regulation & Policy

Related news

Follow us

Featured Events

View more

Products

View more

Webinars